In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
Amidst the challenges, however, there are inspiring stories of individuals who have found success in managing their PCOS symptoms through the incorporation of GLP-1 therapies
HaraNAlkananiAKIrDRobertsonCEWagnerBDFrankDNet al
For patients with Child-Pugh B or C liver disease who are interested in GHK-Cu for wound healing, skin rejuvenation, or hair follicle support, topical application represents the evidence-supported route
ATHLETE'S CHOICE: L-Carnitine 100.000 wurde sowohl fr Leistungs- als auch fr Freizeitsportler entwickelt und untersttzt sie bei intensiven Trainingseinheiten oder Wettkmpfen